NCT06886074
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Hospital Universitario Dr. Jose E. Gonzalez Monterrey, Nuevo León, Mexico
Clinical trial condition
Measurable Residual Disease (MRD)
Explore clinical trials studying Measurable Residual Disease (MRD). Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Measurable Residual Disease (MRD) trial results
Not Yet Recruiting
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study
NCT07264010
- Conditions
- Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
Not specified
NCT04827745
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States